Clinical Trial

Mediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis Remission

Study acronym: MEDITIME-UC
Recruiting
View on ClinicalTrials.gov →
Summary
This study will evaluate whether a 12-week dietary intervention can improve gut health, inflammation, and quality of life in adults with ulcerative colitis in remission. Participants will be randomly assigned to one of three groups: a Mediterranean diet, a Mediterranean diet combined with time-restricted feeding (eating within an 8-hour window each day), or standard dietary advice. The Mediterranean diet emphasizes fruits, vegetables, whole grains, legumes, nuts, olive oil, and fish, while limiting processed foods and red meat. The main outcome will be changes in short-chain fatty acids in stool samples, which are markers of gut health. Additional outcomes include changes in inflammation markers, gastrointestinal symptoms, and quality of life. The results of this study may help identify effective dietary strategies to support patients with ulcerative colitis.
Trial Details
NCT Number NCT07752446
Lead Sponsor Pontificia Universidad Catolica de Chile
Conditions Ulcerative Colitis (Disorder), Inflammatory Bowel Disease (IBD)
Enrollment 45 participants
Start Date 2026-04-10
Primary Completion 2027-04-10 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-07